Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

63.40 USD +1.00 (+1.60%)
Streaming Delayed Price Updated: 3:41 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,603,571
Open 62.30
Bid (Size) 63.39 (28)
Ask (Size) 63.41 (19)
Prev. Close 62.40
Today's Range 62.22 - 63.60
52wk Range 56.56 - 85.97
Shares Outstanding 1,300,260,832
Dividend Yield 3.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
January 12, 2021
From GlobeNewswire News Releases
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
January 12, 2021
Gilead Sciences, Inc. (NASDAQ: GILD) and Vir Biotechnology, Inc. (NASDAQ: VIR) today announced that the companies have entered into a clinical collaboration to evaluate novel therapeutic combination... 
From Business Wire News Releases

Performance

YTD
+5.47%
+5.47%
1 Month
+6.68%
+6.68%
3 Month
+0.70%
+0.70%
6 Month
-17.28%
-17.28%
1 Year
-1.09%
-1.09%

More News

Read More
Gilead Sciences Announces Updated 2020 Guidance
January 11, 2021
From Business Wire News Releases
IBB, AMGN, GILD, REGN: Large Inflows Detected at ETF
Today 11:33 EST
Tags ETFs
From ETF Channel
Gilead Stock 2021: Why The Biotech Stock Isn't Depending On Covid Drugs
Today 12:03 EST
From Investor's Business Daily
Is Novavax's Growth Story Over?
Today 6:25 EST
Tags MRNA SNY GILD
From Motley Fool
3 Top Biotech Picks for January
January 13, 2021
Tags TRIL AMGN ILMN
From Motley Fool
Is Gilead Sciences a Good Coronavirus Stock to Buy?
January 13, 2021
Tags GILD Market News
From Motley Fool
Gilead CEO: We Expect Remdesivir To Work On New COVID-19 Strains
January 11, 2021
Tags GILD Market News remdesivir
From Benzinga
1 Big Reason Trillium Therapeutics Stock's Hot Streak Will Continue in 2021
January 12, 2021
Tags Market News GILD TRIL
From Motley Fool
Understanding Gilead Sciences's Unusual Options Activity
January 11, 2021
Tags Market News GILD Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media